This SEER analysis found that the use of IMRT for prostate cancer is not associated with increased risks of hematologic or solid malignancies compared to 3D conformal. In fact, for patients treated in the early 2000’s, IMRT was associated with a lower risk. However, that difference dissipated over time. | Pithadia, JAMA Oncol 2023
